HAUGEN JANET BRUTSCHEA
Transaction: 06/30/2026
BUY
Change
+46
Price
Not reported
Filing
07/01/2026
Type
BUY
West Pharmaceutical Services, Inc.
WST • Medical - Instruments & Supplies
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$25.11B
Growth
6.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 16.1%Positive free cash flow · 6.49Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 3.02
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$25.11B
52W Range223.83 - 386.00
Beta1.16
Gross Margin35.89%
Oper. Margin20.09%
Profit Margin16.06%
Debt/Eq0.13
Current Ratio3.02
Quick Ratio2.34
Revenue 5Y6.84%
Price$0.00
Change0.00%
Market Cap$25.11B
52W Range223.83 - 386.00
Beta1.16
Gross Margin35.89%
Oper. Margin20.09%
Profit Margin16.06%
Debt/Eq0.13
Current Ratio3.02
Quick Ratio2.34
Revenue 5Y6.84%
Target$370.25
Target Median$377.50
Target Range295.00 - 447.00
Volume1.80M
Avg Volume811.53K
EPS Surprise0.45
Investment DNA
How strong this company looks for long-term investors
71
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
68/100
Price Attractiveness
Cheap or expensive today
34/100
Why this score▼
Stable or improving margins · 16.1%Positive free cash flow · 6.49Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 3.02Expensive earnings multiple · 40.29
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-24
Low
$295.00
Mean
$370.25
Median
$377.50
High
$447.00
Insider Transactions
Recent executive and insider activity
Campbell Shane Alden
Transaction: 05/12/2026
SELL
Change
—
Price
$312.07
Filing
05/14/2026
Type
SELL
Campbell Shane Alden
Transaction: 05/12/2026
SELL
Change
—
Price
Not reported
Filing
05/14/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| HAUGEN JANET BRUTSCHEA | BUY | +46 | Not reported | 06/30/2026 | 07/01/2026 |
| Campbell Shane Alden | SELL | — | $312.07 | 05/12/2026 | 05/14/2026 |
| Campbell Shane Alden | SELL | — | Not reported | 05/12/2026 | 05/14/2026 |
| BUTHMAN MARK A | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Feehery William F | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| FRIEL ROBERT F | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| HAUGEN JANET BRUTSCHEA | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Joseph Molly | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Keller Deborah L | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| LAI GOLDMAN MYLA | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Lockhart Stephen H | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Michels Douglas A | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Pucci Paolo | BUY | +791 | Not reported | 05/04/2026 | 05/06/2026 |
| Winters Chad | SELL | -896 | $173.22 | 04/27/2026 | 04/29/2026 |
| Winters Chad | SELL | -896 | $300.67 | 04/27/2026 | 04/29/2026 |
| Favorite Annette F | SELL | -2,817 | $83.47 | 04/27/2026 | 04/29/2026 |
| Favorite Annette F | SELL | -2,817 | $305.20 | 04/27/2026 | 04/29/2026 |
| HAUGEN JANET BRUTSCHEA | BUY | +52 | Not reported | 03/31/2026 | 04/01/2026 |
| Winters Chad | BUY | +340 | Not reported | 03/01/2026 | 03/03/2026 |
| Winters Chad | BUY | +808 | $254.34 | 03/01/2026 | 03/03/2026 |